INTER-INDIVIDUAL VARIATIONS IN TACROLIMUS TREATED PATIENTS WITH RENAL TRANSPLANTS: CASE FOR PHARMACOGENTIC MONITORING

Journal Title: Innoriginal: International Journal Of Sciences - Year 2017, Vol 4, Issue 1

Abstract

Objectives: Tacrolimus is a widely used drug for renal transplant now a days. In India, it popularity has grown in recent times. One of the important feature of tacrolimus metabolism is that it has wide variation in pharmacokinetcics. Main reasons of pharmacokinetic variations are variations in intestinal and hepatic metabolism. As a result; there are wide intra and inter-patient variations. However, the incidence of these variations is not clearly known. Pharmacogentic monitoring of drugs with unpredictable pharmakinetics could be a new tool towards individualization of drug therapy. It has been known for some time that inter-individual variations contribute to drug toxicity and inferior transplant outcomes. We were interested in studying the relationship between dose and concentration in Indian patients who underwent renal transplant and to know its implications. Methods: A total of 102 patients (age range; 17-60 M:F; 87:15, mean age=29.68±20) were prescribed tacrolimus and their blood levels were analyzed to know variations in their blood levels. Oral tacrolimus therapy was initiated at a dose between 0.1 and 0.15 mg/kg/day. For monitoring tacrolimus blood concentration, blood samples were collected between 7 AM and 8 AM. Estimation of tacrolimus blood levels were done using Microparticle Enzyme Immunoassay (i Max-Abbott, USA). The analytic sensitivity of the test is 1.5ng/ml. Results: A total of 102 patients had a mean age of 29.68±20 years (age range 17-65 years). Plasma levels (ng/ml) were 10.82±7.3, 10.6±5.7, 8.92±3.85, 7.89±2/9 in the 1st, 2nd, 4th and 8th weeks respectively. The respective blood levels mentioned above were obtained with mean dosages (in mg) 7.15±6.1, 7.23±8.1, 5.94±2.5, 5.82±2.7. Multivariate analysis showed no reliable relationship between dose and concentration. Conclusions: Dose response relationship of tacrolimus is poor and routine pharmacokinetic monitoring is needed to identify patients who have low levels of this drug.

Authors and Affiliations

VIKAS DHIKAV, SANDEEP GULERIA

Keywords

Related Articles

GRANGEA MADERASPATANA (L.) POIR. – A COMPREHENSIVE REVIEW

Grangea maderaspatana (L.) Poir. is a popular Indian medicinal plant belonging to the Asteraceae family. This plant commonly known as Madras Car- pet grown in wet places. A wide range of phytochemical constituents have b...

ISOLATION, OPTIMIZATION AND QUANTIFICATION OF EXOPOLYSACCHARIDE PRODUCING BACTERIUM FROM WASTE WATER

Exopolysaccharides (EPS) are high molecular weight polymers which are long chain composed of sugar residues and secreted by microorganisms into the surrounding environment. Bacterial EPS as a complex mixture of macro mol...

EVALUATION OF ANTI-DIARRHOEAL ACTIVITY OF AMARANTHUS TRICOLOR LINN IN EXPERIMENTAL ANIMALS

Objective: To evaluate the anti-diarrhoeal activity of different extracts of the leaves of Amaranthus tricolor Linn. using different animal models. Methods: The shade dried leaves of Amaranthus tricolor.L was extracted...

DIFFERENT SPECTRAL DATA PROCESSING TECHNIQUES FOR DETERMINATION OF LEDIPASVIR AND SOFOSBUVIR IN THEIR PURE AND DOSAGE FORMS; A COMPARATIVE STUDY

Four techniques were described for simultaneous determination of sofosbuvir and ledipasvir in their pure and pharmaceutical dosage forms.The first and second methods describe the development of classical least squares (C...

DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF CEFIXIME AND LINEZOLID IN TABLET DOSAGE FORMS

A simple, precise, stability indicating new RP-HPLC method was developed and validated for the Simultaneous determination of Cefiximeand Linezolid. In this method separation of liquid was done by using column Inertsil OD...

Download PDF file
  • EP ID EP427464
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

VIKAS DHIKAV, SANDEEP GULERIA (2017). INTER-INDIVIDUAL VARIATIONS IN TACROLIMUS TREATED PATIENTS WITH RENAL TRANSPLANTS: CASE FOR PHARMACOGENTIC MONITORING. Innoriginal: International Journal Of Sciences, 4(1), 1-6. https://europub.co.uk/articles/-A-427464